---
title: "‘Follow the Cash,’ Says Top Investor About Oracle Stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306148182.md"
description: "Top investor Keith Noonan warns that Oracle's stock is riskier than earnings suggest due to heavy reliance on OpenAI, which accounts for nearly half of its $664 billion backlog. Despite strong revenue growth, Oracle faces negative free cash flow and high debt from capital expenditures. While analysts rate it a Strong Buy with an 111% upside, Noonan advises following the cash flow rather than just profits."
datetime: "2026-11-19T15:59:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306148182.md)
  - [en](https://longbridge.com/en/news/306148182.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306148182.md)
generator: "portal-rs"
---

# ‘Follow the Cash,’ Says Top Investor About Oracle Stock

On the day Wall Street finally gets its hands on a frontier AI lab, **Oracle** (**NYSE:ORCL**) shareholders have reason to look past the party. Anthropic starts trading on the Nasdaq today after pricing above its marketed range in the largest IPO ever. OpenAI, the lab that matters most to Oracle, is still private and is reportedly aiming for a 2027 listing.

That matters because Oracle’s growth plans depend heavily on OpenAI being able to keep raising money. OpenAI accounts for nearly half of Oracle’s backlog, and the ChatGPT maker’s latest private round has reportedly reached $15 billion, half of its original goal. Anthropic just showed that public investors will hand an AI lab $81.3 billion in one go, but OpenAI can’t tap that pool yet.

Oracle shares currently trade almost two-thirds below their September 2025 record.

Keith Noonan, who contributes to The Motley Fool and ranks among the top 3% of investors on TipRanks, sees that reliance on a single customer as a big reason Wall Street has lost its nerve on the stock.

Oracle closed its fiscal first quarter on Aug. 31 with $664 billion in remaining performance obligations, meaning work customers have signed up for that hasn’t turned into revenue yet. At least $300 billion of that is widely thought to come from OpenAI. The investor points out that the contract terms aren’t public. Oracle would probably collect cancellation fees if OpenAI pulled back, but a fee is only worth something if the customer can pay it. In his view, Oracle has staked its future on OpenAI growing into its commitments. Noonan adds that this kind of exposure bites harder in AI infrastructure, where data centers cost a fortune to build and run.

So far, the results show no strain. First-quarter revenue rose 30% year over year to $19.3 billion, cloud sales jumped 62% to $11.6 billion, and adjusted EPS climbed 30% to $1.92. At today’s price, the stock trades at roughly 14 times the $8.10 in non-GAAP EPS management is guiding to for fiscal 2027. Noonan agrees those numbers make Oracle look cheap, but he doesn’t think they tell the full story.

The cash flow statement is less comfortable. Oracle brought in $23 billion in operating cash during the quarter but spent about $28.5 billion on capex, leaving free cash flow at negative $5 billion. Because a data center counts as an investment on the balance sheet rather than a cost on the income statement, the investor notes, reported earnings understate how much money is going out the door. Oracle is plugging the gap with borrowing and share sales. It carries about $125 billion in debt, plans $90 billion to $95 billion in capex this fiscal year, and will probably keep spending big after that.

For Noonan, fast growth and a low multiple don’t outweigh a debt-funded build-out tied this closely to one customer, and he sees Oracle stock as riskier than its earnings make it look. (To watch Noonan’s track record, click here)

Most on the Street, however, take an optimistic stance here. Based on a mix of 28 Buys, 4 Holds and 1 Sell, the analyst consensus rates the stock a Strong Buy. At $241.83, the average price target implies shares will gain 111% in the months ahead. (See ORCL stock forecast)

*Disclaimer: The opinions expressed in this article are solely those of the featured investor. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.*

### Related Stocks

- [ANT.US](https://longbridge.com/en/quote/ANT.US.md)
- [ORCL.US](https://longbridge.com/en/quote/ORCL.US.md)
- [ORAC.US](https://longbridge.com/en/quote/ORAC.US.md)
- [ORCS.US](https://longbridge.com/en/quote/ORCS.US.md)
- [ORCU.US](https://longbridge.com/en/quote/ORCU.US.md)
- [ORCX.US](https://longbridge.com/en/quote/ORCX.US.md)
- [ORCZ.US](https://longbridge.com/en/quote/ORCZ.US.md)

## Related News & Research

- [Oracle Says OpenAI Contract Is Fully Funded, Not Dependent on Further Vendor Talks](https://longbridge.com/en/news/306327746.md)
- [Oracle says OpenAI contract does not depend on new vendor financing](https://longbridge.com/en/news/306340455.md)
- [Oracle says OpenAI infrastructure deal is fully funded after final capital raise](https://longbridge.com/en/news/306332786.md)
- [‘Nobody Knows,’ Says Investor on Anthropic Stock](https://longbridge.com/en/news/306309262.md)
- [Crypto traders vs. Wall Street: OKX’s Anthropic markets put IPO pricing to the test](https://longbridge.com/en/news/306124839.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**